
United States · Research startup
Qvin, founded in 2014 by Dr.
Funding reportedLast round: Undisclosed round
Qvin, founded in 2014 by Dr.
Sara Naseri and Søren Therkelsen, is a women's health technology company based in Menlo Park, California. The company focuses on transforming menstrual blood into a valuable resource for health diagnostics, offering a non-invasive alternative to traditional blood testing. Qvin aims to empower individuals who menstruate by providing convenient health monitoring solutions, targeting an estimated 2 billion menstruating people worldwide. Qvin's flagship product, the Q-PadTM, is the first FDA-cleared menstrual pad designed for diagnostic testing. It allows users to collect menstrual blood without needles, enabling analysis of various health indicators through a connected mobile app. The service includes at-home sample collection, laboratory analysis, and digital health insights, making it easier for users to manage their health proactively. Qvin is committed to improving women's healthcare by advocating for autonomy and accessibility in health monitoring.
Funding, as reported
What they build
Known for
health caremedical innovationdigital healthconsumerswomen's healthbiotechnology researchlab testingmenstrual blood researchfda-clearedprivacy and securitybiomarker detectioninformation technology & servicesclinical researchnon-invasive diagnosticshospital & health carebiomarkers
Built with from their website
Google WorkspaceWP EngineGoogle MeetFirebaseTwilio SendGrid Email Marketing CampaignsMySQLZendesk for ServiceWordpressSendgridZendesk
PHPZendesk Support SuiteTwilio SendGrid Email APIGoogle Search ConsoleGmail
Add your raise, your deck and your story, and put Qvin in front of investors. Or tell us what we have wrong.